PharmaShots | Incisive News in 3 Shots

Subscribe Now

Regultaory

Jazz' Xywav Receives the US FDA's Approval for the Treatment of Idiopathic Hypersomnia

Jazz' Xywav Receives the US FDA's Approval for the Treatment of Idiopathic Hypersomnia

August 13, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us